What is Enliven Therapeutics's gain/(loss) on dispositions, net?

Enliven Therapeutics (ELVN) reported gain/(loss) on dispositions, net of -$26.5K in Q4 2025.

How has Enliven Therapeutics's gain/(loss) on dispositions, net changed year-over-year?

Enliven Therapeutics's gain/(loss) on dispositions, net decreased by 863.6% year-over-year, from -$2.75K to -$26.5K.

Enliven Therapeutics ELVN Gain/(loss) on dispositions, net

Gain/(loss) on dispositions, net at other companies

Enterprise Products PartnersEPD

-$1M-150%

Datadog, Inc.DDOG

-$1.13M-882%

Comfort Systems USAFIX

$302K-45.7%

Molson Coors Beverage CompanyTAP

$2.4M+129%

NXP SemiconductorsNXPI

$627M+2,750%

The GEO GroupGEO

$58.1M+8,094%

Other financials

Income statement

See full

Operating income-$27.8M+12.2%

Net income-$23.6M+17.2%

EPS (diluted)-$0.38+33.3%

Balance sheet

See full

Cash & equivalents$132.2M+30.0%

Total debt$302.0K-56.9%

Total equity$453.4M+57.3%

Total assets$464.9M+53.6%

Cash flow

See full

Operating cash flow-$19.3M+20.0%

CapEx--100%

Free cash flow-$19.3M+20.1%

Valuation

See full

Market cap$3.47B+143%

Enterprise value$3.34B+156%

Returns & leverage

See full

Return on equity-26.6%-3.5pp

Debt / equity0×0.0×

Current ratio40.3×+19.3×

Where this comes from

Reported directly by Enliven Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.

The official record: Enliven Therapeutics’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's gain/(loss) on dispositions, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enliven Therapeutics's gain/(loss) on dispositions, net?: Enliven Therapeutics (ELVN) reported gain/(loss) on dispositions, net of -$26.5K in Q4 2025.
How has Enliven Therapeutics's gain/(loss) on dispositions, net changed year-over-year?: Enliven Therapeutics's gain/(loss) on dispositions, net decreased by 863.6% year-over-year, from -$2.75K to -$26.5K.